KMTS
Kestra Medical Technologies Stock Analysis
AI Rating
- Quality1/10
- Growth↓ 3/10
- Momentum↓ 0/10
KMTS Growth
- Revenue Y/Y↑ 62.06%
- EPS Y/Y↑ 15.92%
- FCF Y/Y↓ -31.42%
KMTS Profitability
- Gross margin ↑ 46.40%
- EPS margin↓ -186.90%
- ROIC↓ -180.50%
KMTS Risk
- Debt / Equity↓ 0.3
- Debt / FCF↓ 0.0
- Interest coverage↓ -16.8
Kestra Medical Technologies stock volatility is in-line with the overall market. We give it a Great risk rating.